Venus Remedies Secured Marketing Authorisation for 2 Drugs in Europe, Shares Jump almost 5%
Shares of Venus Remedies reached near their 52-week high price after the fixed-dosage injectable manufacturer announced receiving marketing authorisation for two new drugs in Malta,...